Women’s health has been neglected for far too long, and investing in women’s health is an investment, not a cost. The COVID-19 pandemic has disproportionately affected women’s health, making it crucial to prioritize women’s health and allocate resources to this critical area.
Maternal Mortality: A Serious Issue
In the United States, the maternal mortality rate is the highest of all developed countries, and over 80% of pregnancy-related deaths are preventable. This indicates the urgent need for greater investment in women’s health and maternal care.
Promising Innovations, but More Investment Needed
While there are some promising indications of innovation in women’s health worldwide, more investment is necessary to create a sustainable ecosystem of research and development. Currently, only about 1% of healthcare research and innovation is invested in female-specific conditions beyond oncology, indicating a significant gap in research and development that needs to be bridged to address women’s health issues effectively.
The Economic Benefits of Investing in Women’s Health
Investing in women’s health is not just a moral imperative, but it also has economic benefits. As per a report by McKinsey, investing $300 million in women’s health research across three diseases can yield $13 billion in economic returns, illustrating the multiplier effect of investing in women’s health.
Conclusion: Making the Case for Investing in Women’s Health
To address the urgent need for greater investment in women’s health, policymakers need to make a strong case for allocating resources to this critical area. By prioritizing women’s health and emphasizing the economic benefits of investing in women’s health, policymakers can create a sustainable ecosystem of research and development that will enable new and needed solutions to be discovered, developed and made available to all women.